<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">J Clin Rheumatol</journal-id><journal-id journal-id-type="iso-abbrev">J Clin Rheumatol</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Journal of clinical rheumatology : practical reports on rheumatic &amp; musculoskeletal diseases</journal-title></journal-title-group><issn pub-type="ppub">1076-1608</issn><issn pub-type="epub">1536-7355</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10545291</article-id><article-id pub-id-type="pmcid-ver">PMC10545291.319</article-id><article-id pub-id-type="pmcaid">10545291</article-id><article-id pub-id-type="pmcaiid">10545291</article-id><article-id pub-id-type="manuscript-id">NIHMS1924452</article-id><article-id pub-id-type="pmid">37092898</article-id><article-id pub-id-type="doi">10.1097/RHU.0000000000001972</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1924452</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1924452</article-id><article-version article-version-type="pmc-version">319</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Disease-Modifying Anti-Rheumatic Drug Use and its Effect on Long-Term Opioid Use in Patients with Rheumatoid Arthritis</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Sood</surname><given-names initials="A">Akhil</given-names></name><degrees>MD</degrees><xref rid="A1" ref-type="aff">1</xref><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kuo</surname><given-names initials="YF">Yong-Fang</given-names></name><degrees>PhD</degrees><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Westra</surname><given-names initials="J">Jordan</given-names></name><degrees>MPH</degrees><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Raji</surname><given-names initials="MA">Mukaila A.</given-names></name><degrees>MD</degrees><xref rid="A4" ref-type="aff">4</xref></contrib></contrib-group><aff id="A1"><label>1</label>Division of Immunology &amp; Rheumatology, Stanford University School of Medicine, Palo Alto, CA 94304</aff><aff id="A2"><label>2</label>Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX, 77555-01777</aff><aff id="A3"><label>3</label>Department of Preventive Medicine &amp; Population Health, University of Texas Medical Branch, Galveston, TX, 77555-01777</aff><aff id="A4"><label>4</label>Department of Geriatric Medicine, University of Texas Medical Branch, Galveston, TX, 77555-01777</aff><author-notes><fn fn-type="con" id="FN1"><p id="P1"><underline>Alternate Corresponding Author:</underline> Mukaila A. Raji, M.D., M.S (Pharm)., F.A.C.P., Professor &amp; Director, Division of Geriatrics &amp; Palliative Medicine, Edgar Gnitzinger Distinguished Professor of Aging, Professor, Internal Medicine and Neurology, Professor, Preventive Medicine and Population Health, Adjunct Professor, School of Nursing, Phone: 409.266.9635; Fax 409.747.3585; <email>muraji@utmb.edu</email></p></fn><corresp id="CR1"><underline>Corresponding Author</underline>: Akhil Sood, MD, Division of Immunology &amp; Rheumatology, Stanford University School of Medicine; 300 Pasteur Drive; East Pavilion Floor 3; Palo Alto, CA 94304, Phone: 650-723-5762; Fax: 650-723-9656; <email>soodak@stanford.edu</email></corresp><fn fn-type="COI-statement" id="FN2"><p id="P31">Conflict of Interest: The authors report no conflicts of interest.</p></fn></author-notes><pub-date pub-type="ppub"><day>01</day><month>9</month><year>2023</year></pub-date><pub-date pub-type="epub"><day>26</day><month>4</month><year>2023</year></pub-date><volume>29</volume><issue>6</issue><issue-id pub-id-type="pmc-issue-id">446424</issue-id><fpage>262</fpage><lpage>267</lpage><pub-history><event event-type="nihms-submitted"><date><day>27</day><month>09</month><year>2023</year></date></event><event event-type="pmc-release"><date><day>01</day><month>09</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>01</day><month>09</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-09-01 00:25:27.713"><day>01</day><month>09</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1924452.pdf"/><abstract id="ABS1"><sec id="S1"><title>Background/Objectives</title><p id="P2">The prevalence of chronic pain is high in patients with rheumatoid arthritis, increasing the risk for opioid use. The objective of this study was to assess disease-modifying anti-rheumatic drug (DMARD) use and its effect on long-term opioid use in patients with rheumatoid arthritis.</p></sec><sec id="S2"><title>Methods</title><p id="P3">This cohort study included Medicare beneficiaries with diagnosis of rheumatoid arthritis who received at least 30-day consecutive prescription of opioids in 2017 (n= 23,608). The patients were grouped into non-DMARD and DMARD users, which was further subdivided into regimens set forth by American College of Rheumatology. The outcome measured was long-term opioid use in 2018 defined as at least 90-day consecutive prescription of opioids. Dose and duration of opioid use were also assessed. A multivariable model identifying factors associated with non-DMARD use was also performed.</p></sec><sec id="S3"><title>Results</title><p id="P4">Compared to non-DMARD users, the odds of long-term opioid use were significantly lower among DMARD users (OR 0.89 95% CI 0.83, 0.95). All regimens except non-TNF Biologic + Methotrexate was associated with lower odds of long-term opioid use relative to non-DMARD users. The mean total MME, MME/day, and total days of opioid use were lower among DMARD users compared to non-DMARD users. Older age, males, Blacks, psychiatric and medical comorbidities, and not being seen by a rheumatologist were significantly associated with non-DMARD use.</p></sec><sec id="S4"><title>Conclusion</title><p id="P5">DMARD use was associated with lower odds of long-term opioid use among RA patients with baseline opioid prescription. Factors associated with non-DMARD use represent a window of opportunity for intervention to improve pain-related quality of life in patients living with rheumatoid arthritis.</p></sec></abstract><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>